Homepage

Our commitment

COVID-19

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 ...
Read More
our-mission-and-purpose

Our Mission and Purpose

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine
Read More

Explore Novartis

About Us
Who We Are
Our Work
What We Do
About Us
Corporate Responsibility
Careers
Job Search

Recent Updates

Featured / Mar 18

Coronavirus disease (COVID-19) updates

Novartis is responding to the coronavirus situation with safety of associates and patients globally our primary ...

Learn more
Media Release / Mar 25

Sandoz announces new country head for Japan

Read More
Media Release / Mar 20

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response

Read More
Media Release / Feb 26

Sandoz commits to keep prices stable for basket of essential COVID-19 medicines; Novartis responds to COVID-19 with broad range of initiatives

Read More
Media Release / Jan 31

Sandoz completes acquisition of Aspen’s Japanese operations, strengthening its position in world’s third largest market for generics and off-patent medicines

Read More
View All
US Only: Mary Jo Carden, US Head of Policy, spoke with us about the value and opportunities #biosimilars present to… https://t.co/McpcWCFRFe 4 hours 56 min ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More